News

New Discoveries December 4, 2017

Gene associated with metastatic melanoma identified

Craig J. Ceol, PhD (Damon Runyon Fellow '05-'07) of the University of Massachusetts Medical School, Worcester, and colleagues, have identified a new protein that is involved in metastatic melanoma, the most deadly form of skin cancer. The protein, GDF6, is part of a class of proteins called “growth differentiation factors” that helps cells divide and differentiate into specific cell types. Looking at human melanoma cells, the researchers found that 80 percent of patient tumors had elevated levels of GDF6 and these higher levels correlated to the aggressiveness of the cancer.

Honors and Awards November 30, 2017

Huffington Post features Damon Runyon

Damon Runyon Cancer Research Foundation President and Chief Executive Officer recently spoke with the Huffington Post about current challenges and opportunities in cancer research.

Is America losing the opportunity to finally cure cancer? Maybe.

New Discoveries November 30, 2017

2017 Paul Marks Prize for Cancer Research

Chuan He, PhD (Damon Runyon Fellow '00-'02) of the University of Chicago, Chicago, was named one of this year's winners of the 2017 Paul Marks Prize for Cancer Research. The award recognizes promising investigators aged 45 or younger at the time of nomination for their efforts in advancing cancer research.

New Discoveries November 23, 2017

Clues to the association between Fusobacteria and colon cancer

Matthew L. Meyerson, MD, PhD (Damon Runyon Fellow '95-'98), of the Dana-Farber Cancer Institute, Boston, and colleagues, reported a study that provides clues to the role Fusobacteria may play in the development of human colon cancers. Meyerson was one of the first scientists to discover that Fusobacteria, which normally inhabit the mouth, are closely associated with colon cancer cells but not normal colon cells. Researchers have now confirmed the presence of Fusobacteria in up to half of all colon tumors.

Honors and Awards November 9, 2017

Damon Runyon 2017 Fellow's Retreat—Sharing Ideas, Building a Community

First- and third-year Damon Runyon Fellows look forward to our fall retreat as a time to come together from their separate labs around the country, meet their colleagues and share ideas. This September, Fellows gathered in Beverly, Massachusetts.

New Discoveries November 9, 2017

Progress in monitoring cancer with blood biopsies

This month, Damon Runyon scientists published promising findings on “liquid biopsies.” This non-invasive method isolates and studies circulating tumor DNA (ctDNA)-- free-floating pieces of DNA found in blood plasma that are shed from tumor cells. These studies demonstrated that liquid biopsies are becoming an important tool for monitoring cancer progression, as well as identifying treatment strategies and drug resistance earlier than traditional approaches.

New Discoveries November 8, 2017

New progress toward personalized therapy for ovarian cancer

Ronald J. Buckanovich, MD, PhD (Damon Runyon Clinical Investigator ’08-’11) of the University of Pittsburgh, and colleagues, have developed a process that can grow hundreds of cultured cell masses, called spheroids, from just a few tumor cells derived from a patient. This 3D method yields cells that grow and multiply just as they would inside the body. Currently, researchers are limited to two-dimensional cells grown in petri dishes, which often do not respond to medicines the same way as ovarian cancer cells inside the body.

New Discoveries November 2, 2017

High fiber intake linked to improved survival after colon cancer diagnosis

Increasing evidence shows that diet plays a major role in the development of some cancers. Andrew T. Chan, MD, MPH (Damon Runyon Clinical Investigator ‘08-‘13), of Harvard Medical School and Massachusetts General Hospital, Boston, and colleagues, found that eating more fiber after colorectal cancer diagnosis is associated with a lower risk of dying from colorectal cancer.

Honors and Awards October 30, 2017

A Conversation with Damon Runyon Board Member Peter Van Camp

Damon Runyon:
You and your wife Laura Grant Van Camp have supported three DR Innovators through Nadia’s Gift Foundation. Why is that important to you?

Peter Van Camp:
The opportunity to support Damon Runyon Innovators is important to me and my family as a way to honor the memory of my first wife, Nadia, who succumbed to cancer in 2010. Nadia and I were married for 23 wonderful years. Unfortunately, as has become all too common for too many women, Nadia was diagnosed with breast cancer, and we fought her illness together for eight years. There were some good times during those eight years, and some very brave times on Nadia’s part. Although we lost Nadia’s battle, finding a cure to the cancer that would ultimately claim her became a meaningful purpose for us, and remains meaningful to me today.

Honors and Awards October 26, 2017

Meet George Hill, MD, who became a Damon Runyon Fellow in 1958

GEORGE HILL, MD, became a Damon Runyon Fellow in the 1950’s, and recently reconnected with us at our 2017 Annual Breakfast. He was amazed to learn about the breadth of our innovative research projects.

Asked what advice he might give today’s Damon Runyon Fellows, he said, “The most important thing is to find a really, really good mentor. Science is done as a team; you can’t do it alone. You’ve got to find the best person who will make you work hard. It’s the only way to do it.”

George credits an inquisitive mind for leading him down a path that would take him from the farmlands of Iowa to Yale University and Harvard Medical School, and would ultimately earn him a Damon Runyon Fellowship in 1958, which helped launch a prolific career in oncology.

Damon Runyon News